Clinical Trial Update: Effectiveness Study of Scopolamine Combined With Escitalopram in Patients With MDD [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating the effectiveness of scopolamine combined with escitalopram in patients with major depressive disorder has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Escitalopram (escitalopram)
• SCOPOLAMINE (SCOPOLAMINE)

Snippet

Sponsor: Capital Medical University | Conditions: Major Depressive Disorder | Phase 4 | Status: COMPLETED